79 related articles for article (PubMed ID: 16080041)
1. International Behavioral Neuroscience Society - ninth annual meeting.
Agmo A
IDrugs; 2000 Jul; 3(7):743-4. PubMed ID: 16080041
[TBL] [Abstract][Full Text] [Related]
2. Society for Neuroscience - 39th Annual Meeting. Part 1 - Novel therapies for the treatment of CNS disorders and pain.
Al-Shamahi A; Kirkham K; Hookes L
IDrugs; 2009 Dec; 12(12):731-3. PubMed ID: 19943210
[TBL] [Abstract][Full Text] [Related]
3. International Behavioral Neuroscience Society - Ninth meeting. Neurochemistry of feeding.
Beninger RJ
IDrugs; 2000 Jul; 3(7):745-6. PubMed ID: 16080042
[TBL] [Abstract][Full Text] [Related]
4. Endogenous opiates and behavior: 2007.
Bodnar RJ
Peptides; 2008 Dec; 29(12):2292-375. PubMed ID: 18851999
[TBL] [Abstract][Full Text] [Related]
5. The search for mechanisms of behavior change in evidence-based behavioral treatments for alcohol use disorders: overview.
Huebner RB; Tonigan JS
Alcohol Clin Exp Res; 2007 Oct; 31(10 Suppl):1s-3s. PubMed ID: 17880340
[TBL] [Abstract][Full Text] [Related]
6. [Treatment and rehabilitation programs for young alcoholics: acquiring the ability through group therapies and cognitive-behavioral therapies to communicate with others to lead a new life].
Gotoh M
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2009 Oct; 44(5):579-603. PubMed ID: 19938653
[TBL] [Abstract][Full Text] [Related]
7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
8. Endogenous opiates and behavior: 2005.
Bodnar RJ; Klein GE
Peptides; 2006 Dec; 27(12):3391-478. PubMed ID: 16973239
[TBL] [Abstract][Full Text] [Related]
9. Naltrexone and cognitive behavioral coping skills therapy for the treatment of alcohol drinking and eating disorder features in alcohol-dependent women: a randomized controlled trial.
O'Malley SS; Sinha R; Grilo CM; Capone C; Farren CK; McKee SA; Rounsaville BJ; Wu R
Alcohol Clin Exp Res; 2007 Apr; 31(4):625-34. PubMed ID: 17374042
[TBL] [Abstract][Full Text] [Related]
10. Australian Neuroscience Society--20th Annual Meeting. 30 January-2 February 2000, Melbourne, Australia.
Bellingham MC
IDrugs; 2000 May; 3(5):490-2. PubMed ID: 16100678
[TBL] [Abstract][Full Text] [Related]
11. American Society of Hematology--40th annual meeting. 4-8 December 1998, Miami Beach, FL, USA.
Greengard JS
IDrugs; 1999 Feb; 2(2):94-6. PubMed ID: 16160942
[TBL] [Abstract][Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
13. British Pharmacological Society Cambridge Symposia. 5-7 January 2000, Cambridge, UK.
Lawson K
IDrugs; 2000 Apr; 3(4):373-6. PubMed ID: 16100689
[TBL] [Abstract][Full Text] [Related]
14. Alterations in fos-related antigen 2 and sigma1 receptor gene and protein expression are associated with the development of cocaine-induced behavioral sensitization: time course and regional distribution studies.
Liu Y; Matsumoto RR
J Pharmacol Exp Ther; 2008 Oct; 327(1):187-95. PubMed ID: 18591217
[TBL] [Abstract][Full Text] [Related]
15. Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs.
Palucha A; Pilc A
Pharmacol Ther; 2007 Jul; 115(1):116-47. PubMed ID: 17582504
[TBL] [Abstract][Full Text] [Related]
16. Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders.
McCann DJ
Clin Pharmacol Ther; 2008 Apr; 83(4):627-30. PubMed ID: 18212797
[TBL] [Abstract][Full Text] [Related]
17. [Opioid antagonists and alcohol consumption].
Barrios de Tomasi E; Juárez-González J
Rev Neurol; 2007 Aug 1-15; 45(3):155-62. PubMed ID: 17661275
[TBL] [Abstract][Full Text] [Related]
18. The role of 5-HT(1A) receptors in learning and memory.
Ogren SO; Eriksson TM; Elvander-Tottie E; D'Addario C; Ekström JC; Svenningsson P; Meister B; Kehr J; Stiedl O
Behav Brain Res; 2008 Dec; 195(1):54-77. PubMed ID: 18394726
[TBL] [Abstract][Full Text] [Related]
19. Inflammation Research Association--ninth international conference. Chemokines, signal transduction and new drugs workshops. 1-5 November 1998, Hershey, PA, USA.
Phipp C
IDrugs; 1999 Jan; 2(1):11-4. PubMed ID: 16180159
[TBL] [Abstract][Full Text] [Related]
20. 5-HT(7) receptors in the modulation of cognitive processes.
Cifariello A; Pompili A; Gasbarri A
Behav Brain Res; 2008 Dec; 195(1):171-9. PubMed ID: 18243350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
